Quarterly Transactions Made in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). The information is specifically focused on institutions that hold shares of Adaptimmune Therapeutics PLC.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 7,406,266 | 5,454,982 | 12,861,248 | 4,044,846 | 3,860,125 | 7,904,971 | 4,956,277 | |
| Q4 2021 | 3,540,970 | 4,642,838 | 8,183,808 | 4,737,279 | 1,392,739 | 6,130,018 | 2,053,790 | |
| Q1 2022 | 6,705,096 | 757,469 | 7,462,565 | 1,748,577 | 8,932,799 | 10,681,376 | -3,218,811 | |
| Q2 2022 | 8,197,181 | 936,155 | 9,133,336 | 3,206,170 | 869,482 | 4,075,652 | 5,057,684 | |
| Q3 2022 | 1,190,750 | 737,177 | 1,927,927 | 1,407,137 | 0 | 1,407,137 | 520,790 | |
| Q4 2022 | 7,769,888 | 442,229 | 8,212,117 | 7,363,604 | 90,000 | 7,453,604 | 758,513 | |
| Q1 2023 | 6,049,001 | 224,742 | 6,273,743 | 3,816,130 | 36,400 | 3,852,530 | 2,421,213 | |
| Q2 2023 | 11,260,160 | 19,468,869 | 30,729,029 | 1,758,183 | 0 | 1,758,183 | 28,970,846 | |
| Q3 2023 | 5,628,534 | 667,058 | 6,295,592 | 1,019,134 | 0 | 1,019,134 | 5,276,458 | |
| Q4 2023 | 3,029,317 | 919,034 | 3,948,351 | 4,783,707 | 0 | 4,783,707 | -835,356 | |
| Q1 2024 | 1,663,267 | 28,129,124 | 29,792,391 | 11,287,490 | 0 | 11,287,490 | 18,504,901 | |
| Q2 2024 | 3,122,010 | 213,336 | 3,335,346 | 10,013,266 | 0 | 10,013,266 | -6,677,920 | |
| Q3 2024 | 4,561,193 | 302,475 | 4,863,668 | 2,235,477 | 0 | 2,235,477 | 2,628,191 | |